Delivery Order SPE2DB25D3012-SPE2DB25FWZCU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,276.16 to AmerisourceBergen Drug Corp for 1,000 tablets of Losartan Potassium 100 mg, a commonly prescribed antihypertensive medication. The contract, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, utilizes firm fixed-price terms and requires performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award includes no set-aside designation and was competitively awarded through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,414.81 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $1,084.59 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units. This order, which was competitively awarded without a set-aside designation, represents a firm fixed-price delivery under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania location, with an...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,244.73 for 1,000 tablets of Losartan Potassium 100 mg, with an ultimate completion date of May 6, 2025. This non-set-aside, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- AmerisourceBergen Drug Corp received a delivery order from the Defense Logistics Agency (DLA) valued at $3,404.62 for 1,000 tablets of Losartan Potassium 25 mg, with a completion date of September 19, 2025. The contract was awarded on September 18, 2025, using firm fixed-price terms without set-aside designation, indicating the award was competitively procured. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,663.10. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was awarded competitively without set-aside provisions, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.76 on July 28, 2025, for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 29, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of routine pharmaceutical procurement operations supporting...
- The Defense Logistics Agency awarded a delivery order valued at $6,956.52 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Losartan Potassium 50 mg, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,221.28 and an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,151.65. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was not set-aside and represents a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZCUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,182.31 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Losartan Potassium 100 mg. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within the company's broader pharmaceutical distribution portfolio supporting federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its capability as a critical vendor for military and veteran healthcare systems, with consistent competitively awarded contracts covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/11/25 |